Skip to main content
. 2021 Jan 4;12(1):8. doi: 10.1038/s41419-020-03308-w

Fig. 5. Combination of verteporfin-NP, paclitaxel-NP, and combretastatin-NP decreased ex vivo viability of PDX organotypic slice culture.

Fig. 5

A, B Ex vivo viability analysis (Almar blue assay) of PDX (HCI-001) organotypic slice culture after 120-hr treatment with E-NP (empty-NP), P-NP (paclitaxel-NP, 5 nM), V-NP (verteporfin-NP, 250 nM), C-NP (combretastatin-NP, 5 nM), or different combinations. Data represents means ± SEM, n = 3, *P < 0.05, **P < 0.01.